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We seek to understand the relative contribution of  allelic variations of a particular gene to the 
determination of  an individual's risk ofatherosclerosis or hypertension. Work in progress is focusing 
on the identification and characterization of mutations in candidate genes that are known to be 
involved in determining the phenotypic expression of  intermediate biochemical and physiological 
traits that are in the pathway of causation between genetic variation and variation in risk of  disease. 
The statistical strategy described in this paper is designed to aid geneticists and molecular biologists 
in their search to find the DNA sequences responsible for the genetic component of  variation in 
these traits. With this information we will have a more complete understanding of  the nature of  the 
organization of  the genetic variation responsible for quantitative variation in risk of disease. It will 
then be possible to fully evaluate the utility of measured genetic information in predicting the risk of 
common diseases having a complex multifactorial etiology, such as atherosclerosis and 
hypertension. 
INTRODUCTION 
Numerous quantitative biological traits contribute 
to determining an individual's risk of developing a 
common complex disease such as atherosclerosis or 
hypertension (2). Dietary and life style effects interact 
with these traits to determine a continuous 
distribution of risk among individuals in the 
population at large. The etiological relationships 
among the many causal factors that underlie such 
continuous variation are expected to be complex. 
What is the evidence that leads one to conclude 
that diseases like coronary artery disease (CAD) and 
hypertension have complex etiologies? It is clear that 
each of these disorders aggregates in families, but 
disease is not distributed among relatives in a manner 
consistent with a simple Mendelian model of 
inheritance. The phenotypic possibilities for the many 
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biological risk factor traits that influence risk of 
disease are continuously distributed among relatives. 
There is no known combination of phenotypes in an 
individual for which risk is totally absent or disease an 
absolute certainty. All studies to date suggest that 
interindividual variability in every one of these 
biological risk factor traits is explained by the 
interaction of the effects of differences in many genes 
with exposures to variation in numerous 
environmental factors (7). Furthermore, variation in a 
particular gene may contribute to phenotypic variation 
in more than one of these intermediate biological risk 
factor traits that are in the pathway of causation 
between genetic variation and interindividual 
variability in risk (3). Thus, the complexity of the 
network of causation across interdependent levels of 
biological organization precludes those research 
strategies that seek to find a one-to-one mapping 
between a mutation in one gene and the occurrence of 
disease. 
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There is no universally accepted strategy for 
characterizing the paths of causation between genetic 
variation and interindividual variability in risk of 
atherosclerosis or hypertension. Most researchers 
begin by studying the biochemical and physiological 
traits that have been shown by epidemiological studies 
to be predictors of disease. One first seeks to answer 
the following questions to understand the genetic 
architecture of each of these intermediate risk factor 
traits. How many genes are involved in determining 
interindividual variability? How many functional 
alleles are there for each gene? What is the relative 
frequency of each allele? And, what is the impact of 
each allele on interindividual variation in trait levels, 
on intraindividual variability in levels and on the 
pairwise correlations between traits? Once 
information about genetic architecture is available it 
becomes possible to consider a second step that 
addresses the role that each gene plays in predicting 
risk of disease. Two questions dominate. First, what is 
the contribution of a gene to prediction of risk as a 
consequence of  its impact on a particular intermediate 
trait? Second, does knowing an individual's genetic 
make-up provide information about risk that is not 
provided by measures of available intermediate traits? 
Statistical associations between allelic variation in a 
gene and variability in risk of disease, as a 
consequence of its impact on a particular intermediate 
trait, can suggest directions for laboratory research 
that will enhance our understanding of disease 
etiology. When genetic variation improves prediction 
of risk beyond that provided by available measured 
intermediate traits, one must conclude that there are 
pleiotropic effects of the gene on other unmeasured 
intermediate traits that are also involved in the 
etiology of disease. Progress in understanding etiology 
depends on a dynamic interplay between statistical 
evaluation and laboratory exploration. We consider 
below some aspects of the statistical work. 
The bottom-up approach to defining genetic architecture 
of a quantitative trait 
Sing and Moll (8) discuss the top-down and 
bottom-up strategies for unraveling the genetic 
architecture of a quantitative intermediate risk factor 
trait. In the top-down approach, a biometrical analysis 
is carried out to evaluate the impact of genetic 
variability on phenotypic differences among 
individuals. For example,  complex segregation 
analysis is often used to determine if there is statistical 
evidence for allelic variation at a single locus with 
large phenotypic effects. Families segregating for large 
phenotypic differences are candidates for linkage 
studies to identify the region of the genome where the 
responsible gene may be located. Once there is 
evidence for linkage to a marked region, individuals 
from these families are used in molecular studies to 
characterize the DNA sequences responsible for the 
major phenotypic effects. This approach is limited to 
searching for those few loci that have a major impact 
on interindividual variability. The bottom-up 
approach evaluates the impact of allelic variation in 
candidate genes on phenotypic variability. A gene is a 
candidate if its product is known to be involved in the 
metabolism of the trait(s) of interest. We limit our 
discussion here to the bottom-up approach to 
understanding the genetic architecture of intermediate 
traits. 
In the bottom-up approach, each candidate gene 
is expected to have many allelic forms (6). Most DNA 
sequence variations that define these gene differences 
are not expected to influence variation of an 
intermediate trait (4, 6). Hence, research on a 
candidate gene involves sorting out functional allelic 
differences from those that have no effect on the 
expression of the intermediate trait. When these 
genetic variants have been identified, the individuals 
who carry them can be studied in greater depth. Such 
studies will increase our understanding of the 
etiological pathways between the candidate gene and 
risk of disease. We have been developing a statistical 
method to identify the subset of haplotypes that carry 
functional mutations that are responsible for 
phenotypic differences in quantitative risk factor traits 
in a population. We present here an overview of this 
strategy. Much work remains to be done to offer a 
complete theory. Hence, the following is a summary 
of work in progress. 
The use of cladistics to define genotypic variability 
An overview. It is tempting to approach the 
problem of defining mutations in a candidate gene 
responsible for quantitative phenotypic effects simply 
by comparing the DNA sequences of individuals with 
extremely high values with homologous sequences 
from individuals with extremely low values of the trait 
of interest. Five limitations prevent meaningful 
inferences from this strategy. 1) Individuals selected 
may not have detectable differences in the candidate 
gene region because environmental factors or 
mutations in regions other than that sequenced may 
cause the observed differences in trait levels. 
Comparing individuals with high and low values 
provides no information to guide sequencing work. 2) 
There may be many DNA sequence differences that 
are not involved in determining the observed extreme 
phenotypic differences. Comparing individuals with 
high and low values does not provide a strategy for 
distinguishing those mutations that are responsible for 
the observed phenotypic differences from those that 
do not influence phenotypic expression. 3) There may 
be more than one sequence difference that will give 
the same observed phenotypic difference. 4) Multiple 
mutations in the gene may combine to produce an 
observed effect. Thus, the effect of any particular 
mutation will be small and difficult to distinguish as 
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being involved in determining the observed 
phenotypic differences. 5) Most of the mutations 
responsible for quantitative variation in the 
population at large will not result in extreme values. 
Sampling only individuals with extreme values will 
give a biased view of genetic architecture. 
To address the above issues one must sample 
DNA variation in multiple regions of the candidate 
gene using a representative sample of the population 
at large. Restriction fragment length polymorphisms 
(RFLPs) provide a means to mark specific gene variants. 
Differences in single markers define alleles. Multiple 
markers of the same gene define haplotypes. Haplotypes 
associated with phenotypic effects are those which should 
be sequenced to identify the responsible mutations. 
We have proposed (10) a statistical strategy that 
employs cladistics to identify those haplotypes which 
are likely to carry mutations that determine 
quantitative phenotypic effects. A cladistics analysis 
involves two basic steps. First, a cladogram is 
constructed using the observed haplotypes defined by 
simultaneously considering multiple polymorphic 
restriction sites of the candidate gene. Second, the 
cladogram is used to completely define a powerful and 
efficient analysis of associations between haplotype 
variation and phenotypic variability. 
In the first step of cladogram construction, we 
assume the DNA region being marked is short and 
that recombination and gene conversion in this region 
are rare. Thus, each RFLP arises as a consequence of a 
mutation that has occurred at some point in the 
evolutionary history of the population. All copies of 
the RFLP in the contemporary population being 
studied may be traced through the descendants of the 
individual in whom the mutation first occurred. We 
also assume that the farther back in time that a RFLP 
mutation occurred, the greater the chance that a 
second RFLP mutation has occurred in the 
intervening time period in the haplotype carrying the 
original mutation. It follows from this basic 
evolutionary argument that haplotypes in the present 
population differing by many RFLPs will have 
diverged from a common ancestor longer ago than 
haplotypes that differ by only a few RFLPs. 
Conversely, we assume that the greater the similarity 
between two haplotypes, the closer their time of 
divergence in the evolution of the genetic material 
that is being marked. Hence, the number of RFLP 
differences between two haplotypes may be taken as a 
measure of genetic distance that roughly estimates the 
time of their evolutionary divergence. A cladogram is 
a graphical representation of these evolutionary 
relationships among haplotypes. It contains all of the 
mutational genetic distances among the haplotypes in 
the sample. However, the cladogram is much more 
than a chart of genetic distances; it is more like a map 
that provides detailed information on the specific 
mutational changes that relate one haplotype to any 
other haplotype in the sample. That is, the cladogram 
is analogous to a road map rather than a distance chart 
that is commonly found in an atlas. 
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We employ the method of maximum parsimony 
to construct cladograms. The objective is to link 
together the observed haplotypes into a network that 
involves the fewest mutational steps. This method is 
easy to implement and produces equivalent results to 
more complex methods under the reasonable 
assumption of a short evolutionary time period 
involved in accumulation of mutational differences 
between haplotypes. An illustration of the method of 
parsimony is given in Figure 1 where four RFLPs have 
been used to measure haplotype variation. Here 1 
denotes the presence of a restriction enzyme cleavage 
(cut) site and 0 denotes the absence of a cut site. We 
consider a sample of haplotypes that includes four of 
the possible 16 haplotypes that may be distinguished 
by four restriction sites. They are 1111, 1100,1101 and 
1001. There are 16 possible ways to link these four 
haplotypes into a cladogram. Three of these 
possibilities are also shown in Figure 1. The network 
that requires three mutations to explain the evolution 
of the four haplotypes is considered to be the most 
parsimonious cladogram (9). No haplotype is 
identified as the ancestral form; a root is not necessary 
for the application of the cladogram as a tool to 
identify those haplotypes that carry mutations with 
phenotypic effects. 
The most parsimonious cladogram is then used in 
step two as a tool for the study of associations 
between haplotype variation and phenotypic 
variability. We assume that if an undetected 
functional mutation causing a phenotypic effect 
occurred at some point in the evolutionary history of 
the population, it will be embedded within the same 
historical structure represented by the cladogram. The 
cladogram is used to define a nested analysis of the 
phenotypic differences among groups of individuals 
that differ in degree to which their marker haplotypes 
differ. At each level in the hierarchy, phenotypic 
differences between groups of haplotypes with varying 
degrees of evolutionary divergence are compared. If 
there is a significant phenotypic difference between 
groups, one infers that it is attributable to a functional 
mutation in the gene region being marked. A nested 
analysis defined by the structure of the cladogram is a 
powerful tool which focuses the analysis of 
phenotypic variability on the subset of haplotype 
contrasts that provides the greatest amount of 
information about haplotypes that carry mutations 
having a phenotypic effect. The success of the search 
for this mutation is enhanced by comparison of the 
DNA sequences of two haplotypes that have the 
fewest number of RFLP differences yet are associated 
with a significant phenotypic difference. 
Below we give a previously published example of 
a cladogram built using RFLPs and then turn to how it 
has been applied to the analysis of a sample of 
experimental Drosophila data (10). We close with a 
discussion of the issues that are involved in the 
extension of cladistics to the analysis of human 
quantitative data. 
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Figure 1. - 3 of 16 Possible Cladograms Involving 4 of 16 Possible Haplotypes. 
An application of cladistics to Drosophila Adh data 
To simplify the illustration of our approach, we 
consider markers in the alcohol dehydrogenase (Adh) 
gene region and Adh activity data collected from 
homozygous, inbred lines of Drosophila melanogaster 
by Aquadro et al. (1) .  Adh activity level is 
continuously distributed among 25 inbred lines. 
Details of the analyses to fred mutations responsible 
for genetic variation in Adh activity among these lines 
are given in Templeton et al. (10). In this application 
of cladistics, each inbred line is homozygous for a 
particular haplotype. The consequences of 
heterozygosity encountered in natural human 
populations present a special problem of estimation of 
haplotype frequencies. Work in progress discussed 
below addresses this added complexity. 
Figure 2 presents the most parsimonious 
cladogram o f  25 haplOtypes defined by 14 markers 
located in a 13-kb region of the Adh gene. Each 
haplotype is represented by a number. This network 
of haplotypes represents the minimum number of 
evolutionary steps that interrelate the 14 closely linked 
markers. For example, haplotype labeled as 25 differs 
from haplotype 24 at one marker site and from 
haplotype 22 at two marker sites. Haplotypes that are 
most dissimilar for marker types are positioned at the 
greatest distance. The O's denote intermediate 
haplotypes that were not present in the sample but are 
needed to interconnect the observed haplotypes. 
A one-way analysis of variance, which ignores 
information about the relatedness of the 25 
haplotypes contained in Figure 2, detects significant 
variation in the average level of Adh activity among 
the 25 haplotype classes (Pr < 0.001). It does not, 
however, give information about which haplotypes are 
most likely to carry the mutations that determine 
significant phenotypic effects. One might carry out 
multiple contrasts between pairs of haplotype classes 
to localize the effects to particular haplotypes (5). 
There are 300 possible pairwise contrasts but only 24 
degrees of freedom (independent comparisons) 
available for comparing haplotypes. The difficulty in 
choosing an appropriate algorithm for performing the 
contrasts is discussed by Templeton et al.(10). These 
considerations provide the motivation for using a 
nested analysis defined by the structure of the 
cladogram. 
The cladogram given in Figure 2 completely 
defines the nesting of haplotypes by degree of genetic 
relatedness. Haplotypes that share marker types are 
grouped together into clades (branches). Haplotypes 
that are most dissimilar for marker types are 
positioned farthest apart. Nesting of haplotypes into 
clades according to the similarity of their marker types 
gives a network that represents the evolutionary 
relationships among haplotypes. These relationships 
may be used to select comparisons among groups of 
haplotypes that will be most informative about the 
presence of a mutation with a phenotypic effect. A 
nested analysis of variance is a much more powerful 
alternative to the one-way analysis of variance because 
it takes into account this information about 
relatedness of haplotype classes. This analytical 
approach has the advantage of providing a means to 
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detect the existence of DNA sequence changes in 
haplotypes in different parts of the cladogram that 
must represent different mutational events because of 
the separation of the haplotypes in evolutionary time. 
The nesting of statistical comparisons according to the 
cladogram also allows full use of the available degrees 
of freedom in making all relevant contrasts of 
haplotypes. We now discuss the algorithm for 
grouping of the haplotypes into clades. 
Details of the nesting algorithm are given in 
Templeton et al.(10). Each haplotype is a 0-step clade. 
Beginning at the terminal ends of the branches of the 
cladogram, 1-step clades are formed. The terminal 
haplotypes in Figure 2 are 4, 5, 7, 9, 10, 11, 12, 14, 16, 
18, 19, 21, 23 and 25. The 1-step clades are defined by 
linking these haplotypes to haplotypes that have an 
allelic difference at one marker only. Haplotype 22 
joins with 23 to form a 1-step clade. Other 1-step 
clades include 16 with 15, 25 with 24, 20 with 21 and 18 
and 19 with 17. The 1-step clades are then combined 
to form 2-step clades. To do this each 1-step clade is 
considered to be a terminal clade and connected to 
other 1-step clades that differ for only one marker 
allele. Finally, 3-step clades are formed by joining 2- 
step clades that differ by one marker. 
We next discuss the analysis of variability of Adh 
activity among branches of the cladogram to detect 
the presence of functional mutations. Table 1 presents 
the analysis of variance that is defined by the nesting 
of the 25 Adh haplotypes into 1-, 2- and 3-step clades. 
The first comparison is between the average level of 
Adh activity of the two 3-step clades (denoted X and 
Y in Figure 2). A highly significant difference suggests 
that the 3-step clade, X, that includes haplotypes 1-14 
(average = 7.83 units of activity as nanomoles NAD 
reduced/min./fly) contains a functional mutation that 
is not shared by the 3-step clade, Y, that includes 
haplotypes 15-25 (average = 3.52 units). An asterisk is 
placed in Figure 2 between haplotypes 1 and 15 to 
denote that the two 3-step clades may differ for a 
functional mutation that influences Adh activity. It is 
not possible from this analysis to establish if all the 
haplotypes in clade X (or Y) are homogeneous or if 
reversions and/or other mutations with phenotypic 
effects have occurred. The nested analysis of variance 
within the X and Y clades, and the subsequent 
sequence analysis of haplotypes, can establish the 
extent of genetic heterogeneity within these 3-step 
clades. 
The analysis of differences among 2-, 1- and 0- 
step clades presented in Table 1 focus on comparisons 
among haplotypes within the 3-step clades. There are 
three pairwise comparisons (3 dO of 2-step clades 
within the two 3-step clades. The nested analysis of 
variance suggests that none of these comparisons of 
average Adh activity is statistically significant. 
I,l 
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Figure 2. - The Cladogram of  Adh Haplotypes. 
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TABLE 1. - Nested analysis of Adh activity variability. 
Source df F-stat P value 
3-Step Clades 
2-Step Clades in 3-Step Clades 
1-Step Clades in 2-Step Clades 
0-Step Clades in 1-Step Clades 
1 136.33 0.001 
3 0.78 NS 
6 5.71 0.01 
14 3.62 0.01 
24 
However, the nested analysis of differences among the 
1- and 0-step clades, also presented in Table 1, 
detected significant effects of three additional 
mutations within the 3-step clades. The positions of 
these mutations are denoted in Figure 2 by asterisks. 
There are 6 pairwise comparisons of 1-step clades 
within the five 2-step clades. The significant result 
reported in Table 1 is due to the comparison of 
average Adh activity of individuals with haplotypes 8- 
10 with the average of those having the haplotypes 6, 
7, 11 andl2 included in the same 2-step clade. There 
are 14 pairwise comparisons of 0-step clades 
(haplotypes) within 1-step clades. Only two of these 
comparisons (22 vs. 23 and 17 vs. 19) are involved in 
determining statistically significant differences 
suggesting the presence of two additional functional 
mutations in the Adh gene region. 
The results of the nested analysis of variance 
guide one in making decisions about which 
individuals should be sequenced to define the 
mutations that cause the phenotypic effects detected. 
For example, the marker information used to build 
the cladogram argues that individuals with haplotype 
23 are more similar in their DNA sequence to 
individuals with haplotype 22 than they are to 
individuals with any other haplotype considered. 
Hence, the probability of finding the sequence 
responsible for the observed significant phenotypic 
difference in Adh activity between those individuals 
with haplotype 22 and those with haplotype 23 is 
expected to be maximized by comparing the DNA 
sequence of the Adh gene for individuals with 
haplotype 23 with the sequence obtained from 
individuals with haplotype 22. Likewise, individuals with 
haplotype 17 and those with haplotype 19 are candidates 
for DNA comparisons to detect a second Adh mutation 
that has a significant effect on the level of Adh activity. 
We conclude from the nested analysis of variance, 
defined by the cladogram given in Figure 2 and 
presented in Table 1, that there are four mutations in 
the Adh gene region that have phenotypic effects on 
the level of Adh activity. Assuming that the 
evolutionary relationships among haptotypes defined 
by the marker haplotypes are tree, we conclude that 
these four mutations in the Adh gene, arose at 
different times in the evolutionary history of the Adh 
region being marked. To characterize these mutations, 
the strategy would be to sequence the DNA of 
individuals that share the greatest number of marker 
types used to develop the cladogram but are included 
in different clades having significantly different 
average levels of Adh activity. That is, rather than 
selecting individuals with high and low levels of Adh 
activity for DNA sequencing, the cladistics strategy 
suggests that the sequences of individuals with 
haplotype 22 should be compared with the sequences 
of individuals with haplotype 23; those with haplotype 
17 compared with those with haplotype 19; those in 
the 3-step clade including haplotype 1 compared to 
those in the 3-step clade including haplotype 15 and 
those with haplotype 8, 9 or 10 compared with those 
with haplotype 6, 7, 11 or 12. Comparisons of 
sequences will establish the DNA differences that are 
candidates for explaining the observed phenotypic 
effects. It will also be possible to establish whether a 
recurrent mutation is responsible for the observed 
phenotypic heterogeneity among haplotypes or each 
mutational event involves a unique DNA change. 
Work in progress to facilitate an application of cladistics 
to human data 
Obviously, it will be more difficult to apply this 
strategy to human observational data. However, the 
approach has its greatest potential in our search for 
the genetic basis of quantitative traits that have a 
complex multifactorial etiology. We are currently 
addressing a number of  theoretical issues involved in 
the application of cladistics to the search for mutations 
responsible for quantitative phenotypic effects in 
humans. They include 1) modifications of the 
algorithm for estimating the number and frequency of 
haplotypes suggested by Templeton et al. (11), 2) 
evaluation of the limits of parsimony as a method for 
building cladograms and 3) developing a strategy for 
handling the situation where there is more than one 
parsimonious cladogram that is consistent with the 
observed haplotype data (12). 
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